Characterizing clinical risk profiles of major complications in type 2 diabetes mellitus using deep learning algorithms

利用深度学习算法表征2型糖尿病主要并发症的临床风险特征

阅读:3

Abstract

OBJECTIVE: To develop a self-reportable risk assessment tool for elderly type 2 diabetes mellitus (T2DM) patients, evaluating risks of diabetic nephropathy (DN), retinopathy (DR), peripheral neuropathy (DPN), and diabetic foot (DF) using machine learning, thereby providing new insights and tools for the screening and intervention of these complications. MATERIALS AND METHODS: Data from 1,448 T2DM patients at Xi'an No.9 Hospital were used. After preprocessing, five machine learning algorithms (XGBoost, LightGBM, Random Forest, TabPFN, CatBoost) were applied. Models were trained on 70% of the data and evaluated on 30%, with performance assessed by multiple metrics and SHAP analysis for feature importance. RESULTS: The analysis identified 33 risk factors, including 6 shared risk factors (UACR for DN and DR; diabetes duration for DR, DPN, and DF; IBILI for DF and DPN; history of DN for DR and DF; U-Cr for DR and DF; MCHC for DN and DPN) and 27 unique risk factors. Model performance was robust: for DN, TabPFN achieved an AUC of 0.905 and Random Forest an accuracy of 0.878; for DR, LightGBM attained an AUC of 0.794; for DPN, both TabPFN and CatBoost achieved a perfect recall of 1.000 and F1-score of 0.915; and for DF, LightGBM attaining the highest AUC of 0.704. SHAP analysis highlighted key features for each complication, such as UACR and Y-protein for DN, diabetes duration and TPOAB for DR, history of DN and IBILI for DF, and diabetes duration and SBP for DPN. CONCLUSION: This study employed interpretable machine learning to characterize risk factor profiles for multiple T2DM complications, identifying both common and distinct factors associated with major complications. The findings provide a foundation for exploring personalized risk management strategies and highlight the potential of data-driven approaches to inform early intervention research in T2DM complications.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。